Serial Number
79082720
Owner
Galantos Pharma GmbH Biotechnikum MainzAttorney
Ursula B. DayFiling Date
Apr 15, 2010
MEMOGAIN Trademark
Serial Number: 79082720 • Registration: 3987908
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
April 15, 2010
Registration Date
July 5, 2011
Published for Opposition
April 19, 2011
Cancellation Date
April 15, 2020
Goods & Services
pharmaceutical preparations for the treatment of Alzheimer disease, dementia and Parkinson's disease; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system; veterinary preparations for treating diseases and disorders related to the central nervous system, alzheimer's disease the treatment of other dementias and parkinson's disease for domesticated animals, rats, mice and livestock; sanitary preparations for medical use; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementia, and for the treatment of parkinson's disease, nootropics; pharmaceutical preparations for the treatment of schizophrenia, antidepressants, geriatric preparations, namely, pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease; pharmaceutical preparations, namely, acetyloholinesterase inhibitors for the treatment of diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease; pharmaceutical preparations, namely, cholinergic enhancers for the treatment of diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease; pharmaceutical preparations, namely, cholinomimetics for the treatment of diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease
Pharmaceutical research and development services
